Thrombosis unit at The Ottawa Hospital purchases system to reduce
workload, improve patient care, minimize wait times in emergency rooms
OTTAWA, April 28 /PRNewswire/ - Vocantas Inc., a developer of automated telephone outreach solutions, today announced the sale of its CallAssure solution to The Ottawa Hospital to manage patients in its Thrombosis Program.
This comes as a new study published in the Canadian Medical Association Journal shows that CallAssure was effective in helping The Ottawa Hospital keep thrombosis patients in the proper dosing range an impressive 80 percent of the time. In addition the clinic experienced a 33 percent reduction in staff workload. The purchase and full-time deployment of CallAssure may ultimately allow The Ottawa Hospital Thrombosis Program to efficiently and effectively manage the blood thinners of more than 10,000 patients in the region in this manner.
Thrombosis is a chronic disease characterized by the development of clots in blood vessels. Patients must maintain an optimal level of a blood-thinning agent in their bodies, and so require regular blood testing that can indicate the need for possible and sometimes frequent, adjustments to their dosage of blood thinner. The very high level of human interaction required to schedule testing, and reschedule when patients fail to show up, and then to communicate the test results and any dosage change has meant that optimal disease management is often beyond what healthcare systems can afford. Patients without family doctors must often resort to hospital emergency rooms for their testing, and then they must wait there, often for hours, for the test results and dosage details.
Dr. Marc Rodger, Head of the Thrombosis Program at The Ottawa Hospital, recognized the benefits derived by implementing the system. "CallAssure has the potential to positively impact both the patient and the system," said Dr. Rodger, who is also a senior scientist at the Ottawa Hospital Research Institute and an associate professor of medicine at the
"In addition, our skilled clinical resources can be put to better use by devoting time to patient care rather than spending unproductive time trying to reach patients by telephone."
Working closely with Dr. Marc Rodger and others at The Ottawa Hospital, Vocantas used CallAssure to better manage chronic diseases, by alerting patients of upcoming test requirements and any changes to their care plan. By successfully integrating with dosing technology, CallAssure informed patients immediately when their medication dosage is adjusted.
Patients who were part of the CallAssure technology trial at The Ottawa Hospital were enthusiastic about their experience. "The automated system has made my care more efficient," said Rick Dokomos of Ottawa. "Traveling for three months of the year, as I do, I can rely on the system to contact me about dosing and testing and not have to worry about it - now I can enjoy life."
Other patients have credited the system with keeping them from harm by ensuring their dosing regimen remains on track. "This is my lifeline," said Dianna Siteman, also of Ottawa. "If I don't take my medication properly, I can get into a lot of problems. I think it's great and it's going to help a lot of people."
The challenge of effectively managing chronic disease has been highlighted both here in Canada and in the United States. The 2007 National Physician Survey reported that 80 percent of doctors in Canada said that patients with chronic diseases place the biggest demand on their time. In its 2008 report, the Ontario Health Quality Council reported that nearly 8,000 lives could be saved if the province better monitored and treated patients with chronic conditions such as diabetes and heart disease. Meanwhile, south of the border, the Centers for Disease Control and Prevention report that chronic diseases are the leading causes of death and disability, accounting for 70 percent of all deaths in the U.S., which is 1.7 million each year.
These compelling challenges are behind the application of CallAssure to help manage chronic diseases. CallAssure was first developed and evaluated in collaboration with Dr. Alan Forster, an internal medicine specialist at The Ottawa Hospital, a scientist at the Ottawa Hospital Research Institute and an associate professor of medicine at the
"The Ottawa Hospital has decided to deploy CallAssure as part of an ongoing care plan, a routine part of the patient's care," said Gary T. Hannah, founder and president of Vocantas. "Since the evaluation of the technology, both patients and clinicians have come to depend on the system to keep the care plan on track and to free up skilled people who can now devote their attention to patient care, where it belongs.
"In the process, adoption of a technology solution to manage chronic diseases has the potential to impact grand-scale issues like emergency room waiting times and enrolment capabilities for life-saving programs such as those run by the thrombosis unit."
Vocantas is a developer of interactive voice response systems (IVRS) that use advanced computer telephony and speech technology to provide its customers with cost-effective customer outreach solutions. The company's easy-to-use, turn-key solutions offer customizable core features and optional enhancements that integrate seamlessly with existing systems. Its products have particular application in the healthcare, education, utilities and customer service environments where they have been proven to increase efficiencies while minimizing operational costs. For more information, please visit www.vocantas.com.
About The Ottawa Hospital and its Thrombosis Program
The Ottawa Hospital is a multi-campus, academic health sciences centre serving the 1.2 million residents of Ottawa and Eastern Ontario, both in English and French. The Ottawa Hospital Research Institute and the
Copyright©2009 PR Newswire.
All rights reserved